Overview of metastatic disease of the central nervous system
- 1 January 2018
- book chapter
- Published by Elsevier
- Vol. 149, 3-23
Abstract
No abstract availableKeywords
This publication has 202 references indexed in Scilit:
- Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastasesJournal of Neuro-Oncology, 2011
- Randomized Double-Blind Placebo-Controlled Trial of Bevacizumab Therapy for Radiation Necrosis of the Central Nervous SystemInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Metastatic skull tumors: MRI features and a new conventional classificationJournal of Neuro-Oncology, 2010
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trialThe Lancet, 2010
- Concordant HER2 status between metastatic breast cancer cells in CSF and primary breast cancer tissueBreast Cancer Research and Treatment, 2009
- Sites of distant recurrence and clinical outcomes in patients with metastatic triple‐negative breast cancerCancer, 2008
- Letrozole for brain and scalp metastases from breast cancer—a case reportThe Breast, 2006
- Breast Cancer Metastasis to the Central Nervous SystemThe American Journal of Pathology, 2005
- Postoperative Radiotherapy in the Treatment of Single Metastases to the BrainJAMA, 1998
- Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trialsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1997